TransCode Therapeutics Inc. (RNAZ)
RNAZ trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.68
+3.07% on the day
Market cap
$28.4M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | RNAZ on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001829635 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-07-20 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report FORM 8-K | 8-K | 2026-10-01 |
| Latest proxy | DEFA14A | 2026-07-17 |
Source: SEC EDGAR submissions feed, 323 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NXTC | NextCure Inc. | $6.28 | -5.42% | $28.7M |
| MIRA | MIRA Pharmaceuticals Inc. | $0.6664 | -5.53% | $28.0M |
| IGC | IGC Pharma Inc. | $0.2650 | -3.99% | $27.4M |
| IMMP | Immutep Limited | $3.57 | -2.73% | $26.3M |
| ABVC | ABVC BioPharma Inc. | $0.9790 | -0.08% | $26.1M |
| ATNM | Actinium Pharmaceuticals Inc. (Delaware) | $0.9995 | -5.71% | $31.4M |
| RMTI | Rockwell Medical Inc. | $7.85 | +3.70% | $31.6M |
| ATOS | Atossa Therapeutics Inc. | $2.56 | +7.17% | $25.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier